Photobiomodulation Therapy for Idiopathic Facial Paralysis

NACompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

February 20, 2023

Study Completion Date

February 20, 2023

Conditions
Bell's Palsy
Interventions
DEVICE

MLS laser

Treatments were performed with MLS laser (Mphi laser, ASA Srl, Italy). MLS laser is a class IV NIR laser with two synchronized sources (laser diodes). The first one is a pulsed laser diode, emitting at 905 nm, with 25 W peak power. The second laser diode (808 nm) was operated in a continuous mode with power 1 W. Both of the laser beams were synchronized, the locked waves work within the range 1-2000 Hz.

DRUG

Oral vitamin B1

Oral vitamin B1 10mg, times/day

Trial Locations (1)

Unknown

Beijing TongRen Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Beijing Tongren Hospital

OTHER

NCT05585346 - Photobiomodulation Therapy for Idiopathic Facial Paralysis | Biotech Hunter | Biotech Hunter